SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Formerly About Advanced Micro Devices

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: maceng2 who wrote (1256764)8/25/2020 1:15:09 AM
From: Wharf Rat1 Recommendation

Recommended By
pocotrader

  Read Replies (1) of 1571808
 
"The results look clear to me...as an non medical professional and ordinary citizen you understand."

I'm a retired medical professional, and a, uh... concerned citizen.

From the letter..." Your (Fauci) opinions have influenced the thinking of physicians and their patients, medical boards, state and federal agencies, pharmacists, hospitals, and just about everyone involved in medical decision making."

I would say Dr. Trump's magical thinking has convinced the authors to abandon data-driven science and take up his political cause.

==

Hydroxychloroquine Shouldn’t Be Used at All for Covid, ISDA Says

Jeannie Baumann 8/22

Hospitals should drop using the anti-malarial drug hydroxychloroquine altogether to treat Covid-19 patients, even if it’s in a clinical trial, according to new medical guidelines.

The Infectious Diseases Society of America revised its Covid-19 treatment guidelines Friday, toughening its stance against the use of the anti-malarial drug that’s been widely touted by President Donald Trump as a way to deal with the pandemic.

IDSA now recommends not to use hydroxychloroquine either by itself or along with the antibiotic azithromycin for patients with the coronavirus, even in hospitals. The society previously called for limited use of hydroxychloroquine in trials.

“IDSA’s expert guidelines panel concluded that higher certainty benefits (e.g., mortality reduction) for the use of these treatments are now highly unlikely even if additional high quality data would become available,” the group said in a statement.

Earlier, a National Institutes of Health panel recommended against using hydroxychloroquine with azithromycin, unless in a clinical trial, because of an increased risk of cardiac arrest. The agency halted its own clinical trial of hydroxychloroquine in June.

msn.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext